ML20279A344

From kanterella
Revision as of 17:53, 7 October 2020 by StriderTol (talk | contribs) (StriderTol Bot insert)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Letter to Eb Transmitting Export License Application XSNM3763-04
ML20279A344
Person / Time
Site: 11006195
Issue date: 10/02/2020
From: Peter Habighorst
NRC/OIP/ECNP
To: Swartz R
US Dept of Energy, National Nuclear Security Admin, US Dept of Energy, Office of Nonproliferation & Arms Control
Savoy J
References
Download: ML20279A344 (1)


Text

October 2, 2020 Mr. Robert Swartz Acting Policy Director Office of Nonproliferation and Arms Control National Nuclear Security Administration U.S. Department of Energy 1000 Independence Avenue, S.W.

Washington, DC 20585

Dear Mr. Swartz:

Enclosed is an application (XSNM3763/04), dated September 24, 2020, received by the U.S.

Nuclear Regulatory Commission from Edlow International Company, as an Agent for Australian Nuclear Science and Technology Organization, requesting amendment No. 04 to its existing license, XSNM3763/03. The license presently authorizes the export of low-enriched uranium to Australia for fuel and medical isotope production at the OPAL reactor.

The purpose of the amendment is to extend the date of expiration from December 31, 2020 to December 31, 2022.

There are no changes to the terms and conditions of the existing license being requested.

Therefore, our office is processing this as a minor amendment, and if no comments are received from the public within the 30-day comment period and it is determined that applicable legal requirements are satisfied, the NRC will issue the license.

Sincerely, 10/2/2020 X Peter J. Habighorst Peter J. Habighorst Signed by: Peter J. Habighorst Peter J. Habighorst, Chief Export Controls and Nonproliferation Branch Office of International Programs cc w/enclosures:

R. DeLaBarre, DOS J. Semones, DHS/CBP M. Chen, DOE/NNSA P. Dessaules, DOE/NMMSS R. Bennet, DHS/CBP J. Norles, DOE/NNSA S. Clagett, DOC E. Sauls, DTRA ANSO R. Brens, DOS EURATOM